USA flag logo/image

An Official Website of the United States Government

Clinical Translation of Anti-PECAM-1 Monoclonal Antibody as an

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
96365
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
N43CO201000116
Solicitation Year:
N/A
Solicitation Topic Code:
NCI
Solicitation Number:
N/A
Small Business Information
GENOMIC SYSTEMS, LLC
290 LOWELL AVE PALO ALTO, CA 94301-3723
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: Clinical Translation of Anti-PECAM-1 Monoclonal Antibody as an
Agency: HHS
Contract: N43CO201000116
Award Amount: $198,751.00
 

Abstract:

Most patients who die from cancer succumb to advanced metastatic cancer. These patients, are mostoften treatment-refractory, and comprise the largest untapped market in cancer. We have developed a uniquely effective anti-PECAM-1 monoclonal antibody (mAb)-based therapy. To our knowledge, this mAb is the only treatment that safely and effectively treats advanced tumor metastases, independent of tumor type. Clinical translation of anti-PECAM-1 mAb therapy could revolutionize the treatment of this now-refractory clinical entity. Therefore, we propose to perform the following pre-clinical studies required to translate antiPECAM- 1 mAb-based therapy into phase I clinical trials in cancer patients.

Principal Investigator:

Robert Debs

Business Contact:


6509065631
Small Business Information at Submission:

GENOMIC SYSTEMS, LLC
GENOMIC SYSTEMS, LLC 290 LOWELL AVE PALO ALTO, CA 94301

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No